CD28/B7 Costimulation: A Review - PubMed

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract Publication types MeSH terms Substances LinkOut - more resources CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The current model of T cell activation requires two signals. The first signal is specific, requiring T cell receptor recognition and binding to MHC/Antigen presented by an antigen-presenting cell. The second signal is nonspecific, resulting from the binding of B7 ligand on the antigen-presenting cell with its receptor, CD28, on the T cell. If both signals are provided, the T cell will proliferate and secrete cytokines. Recently, it has been shown that CTLA4, another receptor for B7 that is upregulated following T cell after activation, can deliver an inhibitory signal, downregulating T cell proliferation. The B7 family of ligands has two family members, B7-1 and B7-2. They both bind to CD28 and CTLA4, but they differ in their binding affinity, structure, and temporal expression. Considerable research has been done on the CD28/B7 costimulatory pathway. Different ways of manipulating this pathway could provide insights into the mechanism and treatment of opposing pathological states. Blocking the CD28/B7 pathway could result in immunosuppression, with implications for the treatment of autoimmune diseases, organ transplantation, and graft vs. host disease. Activating the CD28/B7 pathway could be useful for including the immune system to recognize and eliminate tumors that evade the immune system. Finally, the CD28/B7 pathway could be involved with maintaining immune tolerance, as recent studies suggest the preferential binding of the B7-CTLA4 pathway results in the down-regulation of the responding T cells. Thus, the B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses.

PubMed Disclaimer

Publication types

• Review Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Abatacept Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Animals Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, CD Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, Differentiation / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Autoimmune Diseases Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B7-1 Antigen / immunology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B7-1 Antigen / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD28 Antigens / immunology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD28 Antigens / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CTLA-4 Antigen Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cell Differentiation Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Clonal Anergy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Immunoconjugates* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Lymphocyte Activation* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neoplasms / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• T-Lymphocytes / cytology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• T-Lymphocytes / immunology* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Transplantation Immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antigens, CD Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Antigens, Differentiation Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• B7-1 Antigen Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CD28 Antigens Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CTLA-4 Antigen Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• CTLA4 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Immunoconjugates Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Abatacept Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology

• Research Materials

  • NCI CPTC Antibody Characterization Program

[x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.